ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/18/2025
Back to search
Official data from USPTO
GREENWICH ANIMAL HEALTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GREENWICH ANIMAL HEALTH
ST13
US500000079237541Class
5
Filing
79237541
Registration
6031355
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
12/20/2025
Trademark type
Word
Nice classes
5
Filing date
04/24/2018
Registration date
04/14/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/14/2020
Last transaction
12/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
GB
Examiner
LOOK,JEFFREY J
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Jazz Pharmaceuticals Operations UK Limited
GW Pharma Limited
Representatives
Michael T. Olsen Winthrop & Weinstine, P.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinolsfor the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical and medical preparations with cannabinoids as active ingredienta drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances for the treatment of epilepsy associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical preparations and substances for the treatment of convulsions and seizures associated with epilepsy associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical and medical preparations for the treatment of symptoms associated with epilepsy including painmuscle spasticity and spasmsbladder problems and sleep disorders associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; medicinal oils in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of epilepsyconvulsions and seizures associated with Dravet Syndrome and Lennox-Gestaut Syndrome
Publications
History of USPTO decisions and trademark events.
50 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/14/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/20/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/15/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/15/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/15/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/15/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/15/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/15/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/12/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/20/2020
FIMP
FINAL DISPOSITION PROCESSED
08/20/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/14/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/28/2020
PUBO
PUBLISHED FOR OPPOSITION
01/28/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/24/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/16/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/08/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/08/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/01/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/01/2020
ALIE
ASSIGNED TO LIE
12/23/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/20/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/19/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/19/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/19/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/19/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/20/2019
GNFR
FINAL REFUSAL E-MAILED
06/20/2019
CNFR
FINAL REFUSAL WRITTEN
06/20/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/19/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/18/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/18/2019
RFNT
REFUSAL PROCESSED BY IB
10/07/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/17/2018
RFRR
REFUSAL PROCESSED BY MPU
09/17/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/11/2018
CNRT
NON-FINAL ACTION WRITTEN
09/10/2018
DOCK
ASSIGNED TO EXAMINER
09/06/2018
DOCK
ASSIGNED TO EXAMINER
08/30/2018
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
08/29/2018
DOCK
ASSIGNED TO EXAMINER
08/27/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/22/2018
CNRT
NON-FINAL ACTION WRITTEN
08/21/2018
DOCK
ASSIGNED TO EXAMINER
08/14/2018
MAFR
APPLICATION FILING RECEIPT MAILED
08/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/30/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/26/2018
Continuous trademark protection
Get notified about every new filing that threatens GREENWICH ANIMAL HEALTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.